Mobile-health Network Solutions Research and Development Expenses 2023-2023 | MNDR

Mobile-health Network Solutions research and development expenses from 2023 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
Mobile-health Network Solutions Annual Research and Development Expenses
(Millions of US $)
2023 $0
2022 $0
Mobile-health Network Solutions Quarterly Research and Development Expenses
(Millions of US $)
2023-12-31
2023-06-30
2022-06-30
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.006B $0.014B
Mobile-health Network Solutions is a telehealth solutions provider principally in Singapore. The company offer users with a range of seamless and hassle-free telehealth solutions, which encompasses teleconsultation services, including the issuance of electronic medical certificates and delivery of medications to user homes, as well as other personalized services such as weight management programs. Mobile-health Network Solutions is based in Singapore.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $44.935B 57.17
Tempus AI (TEM) United States $12.393B 0.00
Doximity (DOCS) United States $11.901B 52.95
Hims & Hers Health (HIMS) United States $10.549B 87.28
IRhythm Technologies (IRTC) United States $5.208B 0.00
Hinge Health (HNGE) United States $4.462B 0.00
Privia Health (PRVA) United States $2.542B 188.27
Inspire Medical Systems (INSP) United States $2.501B 36.77
Phreesia (PHR) United States $1.667B 0.00
Enovis (ENOV) United States $1.647B 8.71
10x Genomics (TXG) United States $1.630B 0.00
Omnicell (OMCL) United States $1.446B 27.85
Schrodinger (SDGR) United States $1.427B 0.00
Azenta (AZTA) United States $1.402B 61.18
Clover Health Investments (CLOV) United States $1.317B 0.00
Claritev (CTEV) United States $1.117B 0.00
Evolent Health (EVH) United States $1.035B 0.00
Fulgent Genetics (FLGT) United States $0.665B 0.00
Zepp Health (ZEPP) Netherlands $0.509B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Standard BioTools (LAB) United States $0.463B 0.00
Talkspace (TALK) United States $0.424B 126.50
Carlsmed (CARL) $0.370B 0.00
Butterfly Network (BFLY) United States $0.355B 0.00
TruBridge (TBRG) United States $0.287B 50.40
Nyxoah SA (NYXH) Belgium $0.232B 0.00
Outset Medical (OM) United States $0.229B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.222B 0.00
Health Catalyst (HCAT) United States $0.206B 0.00
KORU Medical Systems (KRMD) United States $0.190B 0.00
CapsoVision (CV) United States $0.186B 0.00
MDxHealth SA (MDXH) Belgium $0.134B 0.00
American Well (AMWL) United States $0.117B 0.00
CareCloud (CCLD) United States $0.108B 4.92
EUDA Health Holdings (EUDA) Singapore $0.097B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.093B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.069B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
111 (YI) China $0.057B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.038B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Precipio (PRPO) United States $0.024B 0.00
Healthcare Triangle (HCTI) United States $0.019B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00